BISPECIFIC ANTI-CCL2 ANTIBODIES
The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases. La présente invention c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HO, WEI SHIONG ADRIAN SYDOW-ANDERSEN, JASMIN FENG, SHU BERTINETTI-LAPATKI, CRISTINA GAN, SIOK WAN GERTZ, MICHAEL KACPRZYK, LUKASZ GEORGES, GUY LAM, RUNYI ADELINE RUNZA, VALERIA FISCHER, JENS |
| description | The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.
La présente invention concerne des anticorps anti-CCL2 bispécifiques se liant à deux épitopes différents sur le CCL2 humain, leurs compositions pharmaceutiques, leur fabrication et leur utilisation en tant que médicaments pour le traitement de cancers, de maladies inflammatoires, auto-immunes et ophtalmologiques. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3221735A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3221735A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3221735A13</originalsourceid><addsrcrecordid>eNrjZJB38gwOcHX2dPN0VnD0C_HUdXb2MQKznPxdPF2DeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjsZGRobmxqaOhMRFKAHOfIMo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BISPECIFIC ANTI-CCL2 ANTIBODIES</title><source>esp@cenet</source><creator>HO, WEI SHIONG ADRIAN ; SYDOW-ANDERSEN, JASMIN ; FENG, SHU ; BERTINETTI-LAPATKI, CRISTINA ; GAN, SIOK WAN ; GERTZ, MICHAEL ; KACPRZYK, LUKASZ ; GEORGES, GUY ; LAM, RUNYI ADELINE ; RUNZA, VALERIA ; FISCHER, JENS</creator><creatorcontrib>HO, WEI SHIONG ADRIAN ; SYDOW-ANDERSEN, JASMIN ; FENG, SHU ; BERTINETTI-LAPATKI, CRISTINA ; GAN, SIOK WAN ; GERTZ, MICHAEL ; KACPRZYK, LUKASZ ; GEORGES, GUY ; LAM, RUNYI ADELINE ; RUNZA, VALERIA ; FISCHER, JENS</creatorcontrib><description>The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.
La présente invention concerne des anticorps anti-CCL2 bispécifiques se liant à deux épitopes différents sur le CCL2 humain, leurs compositions pharmaceutiques, leur fabrication et leur utilisation en tant que médicaments pour le traitement de cancers, de maladies inflammatoires, auto-immunes et ophtalmologiques.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=CA&NR=3221735A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=CA&NR=3221735A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HO, WEI SHIONG ADRIAN</creatorcontrib><creatorcontrib>SYDOW-ANDERSEN, JASMIN</creatorcontrib><creatorcontrib>FENG, SHU</creatorcontrib><creatorcontrib>BERTINETTI-LAPATKI, CRISTINA</creatorcontrib><creatorcontrib>GAN, SIOK WAN</creatorcontrib><creatorcontrib>GERTZ, MICHAEL</creatorcontrib><creatorcontrib>KACPRZYK, LUKASZ</creatorcontrib><creatorcontrib>GEORGES, GUY</creatorcontrib><creatorcontrib>LAM, RUNYI ADELINE</creatorcontrib><creatorcontrib>RUNZA, VALERIA</creatorcontrib><creatorcontrib>FISCHER, JENS</creatorcontrib><title>BISPECIFIC ANTI-CCL2 ANTIBODIES</title><description>The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.
La présente invention concerne des anticorps anti-CCL2 bispécifiques se liant à deux épitopes différents sur le CCL2 humain, leurs compositions pharmaceutiques, leur fabrication et leur utilisation en tant que médicaments pour le traitement de cancers, de maladies inflammatoires, auto-immunes et ophtalmologiques.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB38gwOcHX2dPN0VnD0C_HUdXb2MQKznPxdPF2DeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjsZGRobmxqaOhMRFKAHOfIMo</recordid><startdate>20221222</startdate><enddate>20221222</enddate><creator>HO, WEI SHIONG ADRIAN</creator><creator>SYDOW-ANDERSEN, JASMIN</creator><creator>FENG, SHU</creator><creator>BERTINETTI-LAPATKI, CRISTINA</creator><creator>GAN, SIOK WAN</creator><creator>GERTZ, MICHAEL</creator><creator>KACPRZYK, LUKASZ</creator><creator>GEORGES, GUY</creator><creator>LAM, RUNYI ADELINE</creator><creator>RUNZA, VALERIA</creator><creator>FISCHER, JENS</creator><scope>EVB</scope></search><sort><creationdate>20221222</creationdate><title>BISPECIFIC ANTI-CCL2 ANTIBODIES</title><author>HO, WEI SHIONG ADRIAN ; SYDOW-ANDERSEN, JASMIN ; FENG, SHU ; BERTINETTI-LAPATKI, CRISTINA ; GAN, SIOK WAN ; GERTZ, MICHAEL ; KACPRZYK, LUKASZ ; GEORGES, GUY ; LAM, RUNYI ADELINE ; RUNZA, VALERIA ; FISCHER, JENS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3221735A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HO, WEI SHIONG ADRIAN</creatorcontrib><creatorcontrib>SYDOW-ANDERSEN, JASMIN</creatorcontrib><creatorcontrib>FENG, SHU</creatorcontrib><creatorcontrib>BERTINETTI-LAPATKI, CRISTINA</creatorcontrib><creatorcontrib>GAN, SIOK WAN</creatorcontrib><creatorcontrib>GERTZ, MICHAEL</creatorcontrib><creatorcontrib>KACPRZYK, LUKASZ</creatorcontrib><creatorcontrib>GEORGES, GUY</creatorcontrib><creatorcontrib>LAM, RUNYI ADELINE</creatorcontrib><creatorcontrib>RUNZA, VALERIA</creatorcontrib><creatorcontrib>FISCHER, JENS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HO, WEI SHIONG ADRIAN</au><au>SYDOW-ANDERSEN, JASMIN</au><au>FENG, SHU</au><au>BERTINETTI-LAPATKI, CRISTINA</au><au>GAN, SIOK WAN</au><au>GERTZ, MICHAEL</au><au>KACPRZYK, LUKASZ</au><au>GEORGES, GUY</au><au>LAM, RUNYI ADELINE</au><au>RUNZA, VALERIA</au><au>FISCHER, JENS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BISPECIFIC ANTI-CCL2 ANTIBODIES</title><date>2022-12-22</date><risdate>2022</risdate><abstract>The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.
La présente invention concerne des anticorps anti-CCL2 bispécifiques se liant à deux épitopes différents sur le CCL2 humain, leurs compositions pharmaceutiques, leur fabrication et leur utilisation en tant que médicaments pour le traitement de cancers, de maladies inflammatoires, auto-immunes et ophtalmologiques.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3221735A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | BISPECIFIC ANTI-CCL2 ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T11%3A33%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HO,%20WEI%20SHIONG%20ADRIAN&rft.date=2022-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3221735A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |